Nanoparticles that allow for CRISPR genome-editing in adult animals have now been developed by researchers. Using a new nanoparticle-based, nonviral delivery technique, the researchers were able to cut out a disease-causing gene in about 80 percent of liver cells, and permanently lower cholesterol in mice.